PMC:7600245 / 402-720
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T4 | 201-210 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T5 | 253-261 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T2 | 37-47 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
| T3 | 52-65 | Chemical | denotes | dexamethasone | http://purl.obolibrary.org/obo/CHEBI_41879 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T7 | 67-308 | Sentence | denotes | Yet, the research continues so as to identify better clinically relevant therapeutics that act either as prophylactics to prevent the infection or as treatments to limit the severity of COVID-19 and substantially decrease the mortality rate. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 18 | 37-47 | Chemical | denotes | remdesivir | MESH:C000606551 |
| 19 | 52-65 | Chemical | denotes | dexamethasone | MESH:D003907 |
| 22 | 201-210 | Disease | denotes | infection | MESH:D007239 |
| 23 | 253-261 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 24 | 293-302 | Disease | denotes | mortality | MESH:D003643 |